Irfan Lateef is head of the firm’s Electrical, Semiconductor & Computer Technology Litigation committee and also leads the firm’s Japan practice.
With over two decades of experience, Irfan ranks among the premier IP litigators in the "World's Leading Patent Professionals" for the Patent 1000 guide by Intellectual Asset Management (IAM) magazine. He has been listed in the “Legal 500,” and he is included among the Daily Journal’s “100 leading IP attorneys in California” for his extraordinary representation of Toshiba Corp.
Clients turn to Irfan to tackle some of their most technically complex issues. His engineering background gives him the ability to master the technology. His experience includes wireless communications (e.g., GSM, GPRS, UMTS, LTE, 802.11, Wi-Fi, Bluetooth, Zigbee), semiconductors, audio and video decoding technologies (e.g., MPEG), consumer electronics (e.g., televisions, video game consoles, smartphones, tablets), advanced signal processing, and digital and analog circuitry. With a master’s degree in Biomedical Engineering, he possesses unique insight for medical device litigation. He is familiar with noninvasive patient monitoring, breath analyte monitoring, blood component separation, atrial fibrillation devices, ECG and EEG signal processing, imaging (e.g., MRI), and acoustic signal processing.
He is an expert in representing Japanese companies in IP disputes. He has been counsel to Toshiba, Canon Medical, Furuno, Keylex, Takata, Panasonic Avionics and others. He appreciates cultural nuances, can build consensus in evaluating risk, and maintains clear, prompt communications. He also has a beginner’s level of Japanese language proficiency.
Using a litigator’s hindsight perspective to anticipate business opportunities, Irfan also advises clients in areas ranging from initial product design, to IP rights tactics and monetization, to ongoing development and market penetration. He is well-versed in the challenges his clients face and the questions that must be addressed and answered, providing solutions that fit their business and financial objectives.
Passionate about his clients, their innovation and distinctive goals, Irfan is meticulous, considerate, and helpful by nature. He often provides value far beyond mere legal services.
注意深く、慎重で頼りになる人物であり、担当するクライアント、クライアントの開発した技術と独自目標に情熱を持って取り組んでいます。また業務全般にわたって生産的な関係を築くことにより、法的な助言を越えた価値をクライアントにもたらします。『Super Lawyers』誌の優秀な知的財産弁護士に選ばれ、『Intellectual Asset Management (IAM)』誌の『Patent 1000』ガイドの「世界の特許専門家リーダー」にも選ばれています。さらに、「Legal 500」にもその名前が掲載されています。さらに、東芝の代理人としてのその優れた手腕から『Daily Journal』の「カリフォルニア州の知的財産専門弁護士上位100人」にも選ばれています。
- イリノイ大学アーバナ・シャンペーン校（電気工学エンジニアリング理学士号、1993年）、最優秀の成績で卒業、ブロンズタブレット優等賞、Eta Kappa Nu電気工学優等生協会、Tau Beta Pi工学優等生協会
Irfan has received multiple awards for his legal accomplishments:
- Named to IAM Strategy 300: The World’s Leading IP Strategists (2021) which “identifies the individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios”
- Named one of the "World's Leading Patent Professionals" for litigation in the Patent 1000 guide by Intellectual Asset Management (IAM) magazine (2013-2021). In the 2018 guide, Irfan was described as "one of the most experienced trial lawyers in the ITC".
- Recognized as an Honoree in the Lawyers of Color Nation’s Best 2020 List
- Selected for inclusion in the "Southern California Super Lawyers" list for his work in intellectual property litigation from 2010-2021 by Super Lawyers magazine
- Recognized by Legal 500 for Patent Litigation in 2013
- Recognized by the Daily Journal among the 100 leading intellectual property (IP) attorneys in California for 2011. He was also included in the 75 Leading Intellectual Property Litigators list, recognized for his extraordinary representation of Toshiba Corp., a pioneer in notebook computer technology
Quoted in, "Patent Filings, Litigation May Shift in Economic Crisis," an article published by Bloomberg Law. (April 2020)
Quoted in, "Nintendo’s $10 Million Escape a Cautionary Patent Law Tale," an article published by Bloomberg Law. (February 2020)
“The U.S. Supreme Court on Copyright Registration Requirement for Commencing an Infringement Suit,” Journal of the Japanese Group of the International Association for the Protection of Intellectual Property (AIPPI), Vol. 64 No. 11 (November 2019) (in Japanese)
"Issue-Preclusive Effect of Agency Decisions in the Patent Context," The Daily Journal (June 2019)
"Lower Standards for Proving Induced Infringement and Other Favorable Rulings for Patent Holders - Sanofi v. Watson Labs. Inc. CAFC Case -," Journal of the Japanese Group of the International Association for the Protection of Intellectual Property (AIPPI), Vol. 63 No. 7 (July 2018)
"Federal Circuit Report | IP Litigator Issue May/June 2018, Volume 24 Number 3," IP Litigator (May/June 2018)
Quoted in, "Inter Partes Patent Challenges Are Constitutional, US Supreme Court Rules," Medtech Insight (April 2018)
Quoted in, "A Post-IPR World Would Hold Patent Risks and Benefits For Medtech Companies," Medtech Insight (March 2018)
Quoted in, "'Alice' In Patent Land: Finding Patentable Digital Health Innovations Is No Easy Task," Medtech Insight (February 2018)
"Intellectual Property Can Make or Break the Best Ideas," RTC Magazine (March 2016)
"The U.S. Supreme Court on Induced Infringement and Its Impact on Patent Strategy," Journal of the Japanese Group of the International Association for the Protection of Intellectual Property (AIPPI), Vol. 61 No. 2 (February 2016)
"The Impact of Alice on Patent Eligible Subject Matter - With a Focus on U.S. District Courts' and Federal Circuit's Decisions relating to Business Methods and Computer Software-Related Inventions on Decisions," Journal of the Japanese Group of the International Association for the Protection of Intellectual Property (AIPPI), Vol. 60 No. 11 (November 2015)
"Attack on software patents in the United States," Intellectual Property and Entertainment Law, Newsletter of the International Bar Association Legal Practice Division, Vol. 7 Issue 1 (September 2015).
"Another Reason to Coordinate Discovery in Parallel Litigation – Circumvention in Section 1782 Requests," International Litigation News, Newsletter of the International Bar Association Legal Practice Division (April 2013)
“Ten Steps in Analyzing Patent Infringement,” ExecSense, E-book available on Amazon.com (February 6, 2013)
"The Heightened Domestic-Industry Standard for NPEs", Intellectual Property Litigation Newsletter, American Bar Association Section of Litigation, Summer 2012, Vol. 23 No. 4 (September 2012)
“What Medical Device Companies Need to Know about Intellectual Property”, Medical Electronic Device Solutions (MEDS) Magazine (August 2012)
"Be careful what you write: attorney-client privilege for international businesses," International Litigation News, Newsletter of the International Bar Association Legal Practice Division (May 2012)
"The Supreme Court reigns in states' aggressive assertion of personal jurisdiction," North American Regional Forum News, Newsletter of the International Bar Association Legal Practice Division (May 2012)
“An Overview of U.S. Patent Litigation for Canadians,” 28 Canadian Intellectual Property Review 1, 2012
“The U.S. Patent Litigation Process,” IP Osgoode (December 2010)
“Parent/Subsidiary Liability Issues in Patent Litigation,” ABA Intellectual Property Litigation, Vol. 21, No. 2 (Winter 2010)
"The Supreme Court Takes on Patent Law," SideBar, Federal Litigation Section of the Federal Bar Association (Summer 2007)
Co-authored brief for the AIPLA as amicus curiae in Microsoft Corp. v. AT&T Corp. before the Supreme Court of the United States (2007)
Speeches & Seminars
“COVID Impacts on Patent-Related Activites”, Japan Intellectual Property Association (JIPA) AIPLA IP Practice in Japan Committee (February 2021)
“Discretionary Denials in IPRs”, AIPPI / JAPAN US Patent Seminar, Tokyo, Japan (October 2020)
Panelist on "Non-Traditional VC, Family Office, Angel & CrowdSourcing in 2020" (February 2020)
Moderator on Life Science Intelligence Emerging Medtech Summit 2020 (February 2020)
“Strategy for Success in Participatory Review”, AIPPI / JAPAN US Patent Seminar, Tokyo, Japan (October 2019)
"Patent Law Update for Medical Device Companies 2018," MedTech Strategist Innovation Summit, San Francisco, CA (November 2018)
"What Are the USPTO’s Patent Plans for Fiscal Year 2017?" 29th Global Legal & IP ConfEx, Dubai, UAE (September 2016)
“Alice’s Effect on US Patent Litigation,” IIPLA Annual Conference, Dubai, UAE (January 2015)
“Anti-NPE Laws - How recent Case Law, the FTC NPE survey, and the newly proposed Innovation Act affect the Enforcement & Valuation of Patents,” Orange County Patent Law Association (OCPLA) and AIPLA event, Irvine, CA (January 2014)
“Intellectual Property Seminar for Executives and IP Managers," Tokyo, Japan (November 2013)
“eDiscovery and IP Litigation," Seoul, South Korea (November 2013)
"Strategies to Handle U.S. Litigations," Hsinchu and Taipei, Taiwan (September 2013)
"Recent Trends in U.S. Patent Litigation - Litigation involving Standard Essential Patents (SEP) - from Non-Practicing Entities to Practicing Entities," Tokyo, Japan (April 2013)
"Strategies Relating to Preissuance Submission, Post-grant Review and Inter Partes Review," Benrishi Kai (Patent Attorney Association of Japan), Tokyo, Japan (December 2012)
"Strategies for Taking Advantage of the America Invents Act, Resolving the Tension Between Patentable Subject Matter & Joint Infringement," Tokyo, Japan (October 2012)
“Successful Medical Device Development,” Medical Electronic Device Solutions Conference, San Diego, CA (August 2012)
"Developments in ITC Litigation - An Overview For Japanese Companies," UBIC hosted seminar, Tokyo, Japan (April 2012)
Lecturer on “Patent Enforcement” for the “Understanding Intellectual Property Law for the High Technology Industry” course offered by University of California at Irvine.